Anti-Trichomonas vaginalis activity of marine-associated fungi from the South Brazilian Coast

Experimental Parasitology

Volumn 133, Issue 2, 2013, Pages 211-216

  Scopel, Marina ^a   dos Santos, Odelta ^a   Frasson, Amanda Piccoli ^a   Abraham, Wolf Rainer ^b   Tasca, Tiana ^a   Henriques, Amélia T ^a   Macedo, Alexandre J ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Anti Trichomonas vaginalis; Fresh clinical isolates; Marine associated fungi

Indexed keywords

ANTIPROTOZOAL AGENT; METRONIDAZOLE;

ANTIFUNGAL RESISTANCE; ANTIPROTOZOAL ACTIVITY; ARTICLE; BRAZIL; CONTROLLED STUDY; CYTOTOXICITY; DNA SEQUENCE; DRUG DETERMINATION; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; FUNGUS ISOLATION; GROWTH INHIBITION; GROWTH RATE; HYPOCREA LIXII; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE VIABILITY; PENICILLIUM CITRINUM; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TRICHOMONAS VAGINALIS;

ANIMALS; ANTIPROTOZOAL AGENTS; BRAZIL; CERCOPITHECUS AETHIOPS; DRUG RESISTANCE; ERYTHROCYTES; FUNGI; HEMOLYSIS; HUMANS; HYPOCREA; METRONIDAZOLE; MOLECULAR SEQUENCE DATA; PARASITIC SENSITIVITY TESTS; PENICILLIUM; PORIFERA; SEAWATER; TRICHOMONAS VAGINALIS; VERO CELLS;

FUNGI; HYPOCREA LIXII; PENICILLIUM CITRINUM; PROTOZOA; TRICHOMONAS VAGINALIS;

EID: 84871769002     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2012.11.006     Document Type: Article

References (43)

1. Amagata T., Amagata A., Tenney K., Valeriote F.A., Lobkovsky E., Clardy J., Crews P. Unusual C25 steroids produced by a sponge-derived Penicillium citrinum. Org. Lett. 2003, 5:4393-4396.
2. Arora D.S., Chandra P. In vitro antioxidant potential of some soil fungi: screening of functional compounds and their purification from Penicillium citrinum. Appl. Biochem. Biotechnol. 2011, 2:639-651.
3. Bhimba B.V., Franco D.A., Mathew J.M., Jose G.M., Joel E.L., Thangaraj M. Anticancer and antimicrobial activity of mangrove derived fungi Hypocrea lixii VB1. Chin. J. Nat. Med. 2012, 10.3724/SP.J.1009.2012.00077.
4. Blaha C., Duchene M., Aspock H., Walochnik J. In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis. J. Antimicrob. Chemother. 2006, 57:273-278.
5. Blunt J.W., Copp B.R., Hu W.-P., Munro M.H.G., Northcote P.T., Prinsep M.R. Marine natural products. Nat. Prod. Rep. 2007, 24:26-78.
6. Cantillo-Ciau Z., Moo-Puc R., Quijano L., Freile-Pelegrín Y. The tropical brown alga Lobophora variegata: a source of antiprotozoal compounds. Mar. Drugs 2010, 8:1292-1304.
7. Castillo-Machalskis I., D'Armas H., Malaver N., Núñez M. Anti-bacterial activity of extracts from fungi collected from mangrove Rhizophora mangle (Rhizophoraceae) roots in Venezuela. Ver. Biol. Trop. 2007, 55:761-765.
8. Choudary K.A., Reddy K.R.N., Reddy M.S. Antifungal activity and genetic variability of Trichoderma harzianum isolates. J. Mycol. Pl. Pathol. 2007, 37:1-6.
9. Cotch M.F., Pastorek J.G., Nugent R.P., Hillier S.L., Gibbs R.S., Martin D.H., Eschenbach D.A., Edelman R., Carey J.C., Regan J.A., Krohn M.A., Klebanoff M.A., Rao A.V., Rhoads G.G. Trichomonas vaginalis derived with low birth weight and preterm delivery. The vaginal infections and prematurity study group. Sex. Transm. Dis. 1997, 24:353-360.
10. Cudmore S.L., Delgaty K.L., Hayward-McClelland S.F., Petrin D.P., Garber G.E. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin. Microbiol. Rev. 2004, 17:783-793.
11. Cudmore S.L., Garber G.E. Prevention or treatment: the benefits of Trichomonas vaginalis vaccine. J. Infect. Public Health 2010, 3:47-53.
12. Darkin-Rattray S.J., Gurnett A.M., Myers R.W., Dulski P.M., Crumley T.M., Allocco J.J., Cannova C., Meinke P.T., Colletti S.L., Bednarek M.A., Singh S.B., Goetz M.A., Dombrowski A.W., Polishook J.D., Schmatz D.M. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proc. Natl. Acad. Sci. USA 1996, 93:13143-13147.
13. Diamond L.S. The establishment of various Trichomonas of animals and man in axenic cultures. J. Parasitol. 1957, 43:488-490.
14. Du L., Liu H.C., Fu W., Li D.H., Pan Q.M., Zhu T.J., Geng M.Y., Gu Q.Q. Unprecedented citrinin trimer tricitinol B functions as a novel topoisomerase IIα inhibitor. Med. Chem. 2011, 54:5796-5810.
15. Duarte M., Giordani R.B., De Carli G.A., Zuanazzi J.A., Macedo A.J., Tasca T. A quantitative resazurin assay to determinate the viability of Trichomonas vaginalis and the cytotoxicity of organic solvents and surfactant agents. Exp. Parasitol. 2009, 123:195-198.
16. Frasson A.P., Dos Santos O., Duarte M., da Silva, Trentin D., Giordani R.B., da Silva A.G., da Silva M.V., Tasca T., Macedo A.J. First report of anti-Trichomonas vaginalis activity of the medicinal plant Polygala decumbens from the Brazilian semi-arid region. Caatinga. Parasitol Res. 2011, 10.1007/s00436-011-2787-4.
17. Gauthier C., Legault J., Girard-Lalancette K., Mshvildadze V., Pichette A. Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins. Bioorg. Med. Chem. 2009, 17:2002-2008.
18. Gehrig S., Efferth T. Development of drug resistance in Trichomonas vaginalis and its overcoming with natural products. The Open Bioact. Compd. J. 2009, 2:21-28.
19. Gilbert R.O., Elia G., Beach D.H., Klaessig S., Singh B.N. Cytopathogenic effect of Trichomonas vaginalis on human vaginal epithelial cells cultured in vitro. Infect. Immun. 2000, 68:4200-4206.
20. Goldstein F., Goldman M.B., Cramer D.W. Relation of tubal infertility to a story of sexually transmitted diseases. Am. J. Epidemiol. 1993, 137:577-584.
21. Helms D.J., Mosure D.J., Secor W.E., Workowski K.A. Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am. J. Obstet. Gynecol. 2008, 198:370-377.
22. Kasettrathat C., Ngamrojanavanich N., Wiyakrutta S., Mahidol C., Ruchirawat S., Kittakoop P. Cytotoxic and antiplasmodial substances from marine-derived fungi, Nodulisporium sp. and CRI247-01. Phytochemistry 2008, 69:2621-2626.
23. Krashin J.W., Koumans E.H., Bradshaw-Sydnor A.C., Braxton J.R., Evan Secor W., Sawyer M.K., Markowitz L.E. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Sex. Transm. Dis. 2010, 37:440-444.
24. Kuile B.H. Metabolic adaptation of Trichomonas vaginalis to growth rate and glucose availability. Microbiology 1996, 142:3337-3345.
25. Lee Y.K., Lee J.-H., Lee H.K. Microbial symbiosis in marine sponges. The J. Microbiol. 2001, 39:254-264.
26. Machado F.L.S., Kaiser C.R., Costa S.S., Gestinari L.M., Soares A.R. Atividade biológica de metabólitos secundários de algas marinhas do gênero Laurencia. Braz. J. Pharmacogn. 2010, 20:441-452.
27. Mayer A.M.S., Hamann M.T. Marine pharmacology in 2001-2002: marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2005, 140:265-286.
28. Mayer K.H., Bush T., Henry K., Overton E.T., Hammer J., Richardson J., Wood K., Conley L., Papp J., Caliendo A.M., Patel P., Brooks J.T. The SUN investigators, ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventions. Sex. Transm. Dis. 2012, 1:1-7.
29. Moo-Puc R., Robledo D., Freile-Pelegrin Y. Evaluation of selected tropical seaweeds for in vitro antitrichomonalactivity. J. Ethnopharmacol. 2008, 120:92-97.
30. Ni M., Zhou X.Y., He X., Gu Q.Q. A novel hemiacetal from the marine-derived fungus Penicillium citrinum. Yao Xue Xue Bao. 2011, 46:1098-1100.
31. Pontius A., Krick A., Kehraus S., Brun R., König G.M. Antiprotozoal activities of heterocyclic-substituted xanthones from the marine-derived fungus Chaetomium sp. J. Nat. Prod. 2008, 71:1579-1584.
32. Saravanakumar R., Ronald J., Ramesh U., Maheswari K. Molecular analysis of sponge associated bacteria in Gulf of Mannar Coast and their antibacterial activity against fish pathogens. Int. J. Biol. Tech. 2011, 2:19-27.
33. Schwebke J.R., Barrientes F.J. Prevalence of Trichomonas vaginalis isolates with resistance to Metronidazole and Tinidazole. Antimicrob. Ag. Chemother. 2006, 50:4209-4210.
34. Sun Y., Li M., Liu J. Haemolytic activities and adjuvant effect of Anemone raddeana saponins (ARS) on the immune responses to ovalbumin in mice. Int. Immunopharmacol. 2008, 8:1095-1102.
35. Tarus P.K., Lang'at-Thoruwa C.C., Wanyonyi A.W., Chhabra S.C. Bioactive metabolites from Trichoderma harzianum and Trichoderma longibrachiatum. Bull. Chem. Soc. Ethiop. 2003, 17:185-190.
36. Upcroft J.A., Dunn L.A., Wal T., Tabrizi S., Delgadillo-Correa M.G., Johnson P.J., Garland S., Siba P., Upcroft P. Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea. Sex. Health 2009, 6:334-338.
37. van Der Pol B., Kwok C., Pierre-Louis B., Rinaldi A., Salata R.A., Chen P.L., Van de Wijgert J., Mmiro F., Mugerwa R., Chipato T., Morrison C.S. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J. Inf. Dis. 2008, 197:548-554.
38. Viikki M., Pukkala E., Nieminen P., Hakama M. Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol. 2000, 39:71-75.
39. Washida K., Koyama T., Yamada K., Kita M., Uemura D. Karatungiols A and B, two novel antimicrobial polyol compounds, from the symbiotic marine dinoflagellate Amphidinium sp. Tetrahedron Lett. 2006, 47:2521-2525.
40. Watts K.R., Tenney K., Crews P. The structural diversity and promise of antiparasitic marine invertebrate-derived small molecules. Curr. Opin. Biotechnol. 2010, 21:808-818.
41. Watts K.R., Ratnam J., Ang K.-H., Tenney K., Compton J.E., McKerrow J., Crews P. Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi. Bioorg. Med. Chem. 2010, 18:2566-2574.
42. World Health Organization Global Prevalence And Incidence of Selected Curable Sexually Transmitted Infections. Overview And Estimates 2001, WHO, Geneva Switzerland.
43. Zhang, Y., Mu, J., Feng, Y., Gu, X., Zhang, Y., 2011. Marine fungi inhibiting Methicillin-resistant Staphylococus aureus and their molecular taxonomy. In: 5th International Conference on Bioinformatics and, Biomedical Engineering (iCBBE). doi:10.1109/icbbe.2011.5780075.